OVID
Ovid Therapeutics Inc.Company with tickers: OVID
Market Cap
$475.93M
Shares Outstanding
186,640,102
CIK
1636651
CUSIP
690469101
Website
Visit website
Investor Relations
Investor relations
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-06-15 | Greka Anna |
Director | Award | 130,000 |
| 2026-06-15 | Greka Anna |
Director | Other | 0 |
| 2026-04-07 | Friedman Bart |
Director | Award | 8,789 |
| 2026-04-07 | PAPADOPOULOS STELIOS |
Director | Award | 17,578 |
| 2026-04-07 | Fitzgerald Kevin Joseph |
Director | Award | 17,578 |
| 2026-03-23 | LEVIN JEREMY M |
Director, Executive Chairman | Convert | 47,333 |
| 2026-03-23 | LEVIN JEREMY M |
Director, Executive Chairman | Convert | 47,333 |
| 2026-02-26 | LEVIN JEREMY M |
Director, Executive Chairman | Award | 957,000 |
| 2026-02-26 | ALEXANDER MARGARET A. |
Director, President and CEO | Award | 1,435,000 |
| 2026-02-26 | Rona Jeffrey A |
CBFO | Award | 408,750 |
| 2026-02-26 | PAPADOPOULOS STELIOS |
Director | Award | 65,000 |
| 2026-02-26 | Friedman Bart |
Director | Award | 65,000 |
| 2026-02-26 | Rona Jeffrey A |
CBFO | Award | 68,125 |
| 2026-02-26 | Bernstein Karen |
Director | Award | 65,000 |
| 2026-02-26 | Duncan Barbara Gayle |
Director | Award | 65,000 |
| 2026-02-26 | Fitzgerald Kevin Joseph |
Director | Award | 65,000 |
| 2026-02-23 | ALEXANDER MARGARET A. |
Director, President and CEO | Sell | 11,656 |
| 2026-02-23 | Rona Jeffrey A |
CBFO | Sell | 8,541 |
| 2026-01-04 | ALEXANDER MARGARET A. |
Director, President and CEO | Award | 890,000 |
| 2025-12-15 | LEVIN JEREMY M |
Director, Executive Chairman | Other | 71,000 |
| 2025-12-15 | LEVIN JEREMY M |
Director, Executive Chairman | Other | 71 |
| 2025-12-11 | LEVIN JEREMY M |
Director, Executive Chairman | Buy | 47,333 |
| 2025-12-11 | LEVIN JEREMY M |
Director, Executive Chairman | Buy | 35,500 |
| 2025-12-11 | LEVIN JEREMY M |
Director, Executive Chairman | Buy | 71 |
| 2025-12-08 | TAKEDA PHARMACEUTICAL CO LTD |
10% Owner | Other | 1,250 |
| 2025-12-08 | TAKEDA PHARMACEUTICAL CO LTD |
10% Owner | Other | 1,250,000 |
| 2025-03-03 | PAPADOPOULOS STELIOS |
Director | Award | 90,000 |
| 2025-02-26 | Rona Jeffrey A |
CBFO | Sell | 3,902 |
| 2025-02-26 | ALEXANDER MARGARET A. |
Director, President and CEO | Sell | 5,279 |
| 2025-02-20 | Fitzgerald Kevin Joseph |
Director | Award | 45,000 |
| 2025-02-20 | Bernstein Karen |
Director | Award | 45,000 |
| 2025-02-20 | ALEXANDER MARGARET A. |
Director, President and CEO | Award | 43,750 |
| 2025-02-20 | Rona Jeffrey A |
CBFO | Award | 43,750 |
| 2025-02-20 | Friedman Bart |
Director | Award | 45,000 |
| 2025-02-20 | Rona Jeffrey A |
CBFO | Award | 262,500 |
| 2025-02-20 | ALEXANDER MARGARET A. |
Director, President and CEO | Award | 262,500 |
| 2025-02-20 | Duncan Barbara Gayle |
Director | Award | 45,000 |
| 2025-02-20 | LEVIN JEREMY M |
Director, Executive Chairman | Award | 1,650,000 |
| 2025-01-27 | ALEXANDER MARGARET A. |
Director, President and CEO | Buy | 6,810 |
| 2024-12-12 | Bernstein Karen |
Director | Award | 90,000 |
| 2024-12-12 | Fitzgerald Kevin Joseph |
Director | Award | 90,000 |
| 2024-12-12 | Friedman Bart |
Director | Award | 90,000 |
| 2024-12-12 | Duncan Barbara Gayle |
Director | Award | 90,000 |
| 2024-09-09 | ALEXANDER MARGARET A. |
Director, President and CEO | Award | 140,000 |
| 2024-07-30 | Rona Jeffrey A |
CBFO | Award | 315,000 |
| 2024-03-18 | LEVIN JEREMY M |
Director, Executive Chairman | Buy | 18,248 |
| 2024-02-22 | Perone Thomas Michael |
General Counsel, Secretary | Award | 168,750 |
| 2024-02-22 | Duncan Barbara Gayle |
Director | Award | 30,000 |
| 2024-02-22 | Rona Jeffrey A |
CBFO | Award | 168,750 |
| 2024-02-22 | Perone Thomas Michael |
General Counsel, Secretary | Award | 28,125 |
Showing 1–50 of 131 transactions